Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Hortensia, Lison"'
Autor:
Alexandre Pariente, Jean-Pierre Arpurt, Andre-Jean Remy, Isabelle Rosa-Hezode, Xavier Causse, Frederic Heluwaert, Gilles Macaigne, Jean Henrion, Christophe Renou, Matthieu Schnee, Hatem Salloum, Severine Hommel, Christophe Pilette, Ramuntxo Arotcarena, Georges Barjonet, Hortensia Lison, Frangois Bourhis, Vincent Jouannaud, Arnaud Pauwels, Yann Le-Bricquir, Edmond Geagea, Bertrand Condat, Marie-Pierre Ripault, David Zanditenas, Stephanie de Montigny-Lenhardt, Helene Labadie, Bertrand Tissot, Eric Maringe, Jean-Frangois Cadranel, Herve Hagege, Bruno Lesgourgues
Publikováno v:
Annals of Hepatology, Vol 18, Iss 1, Pp 193-202 (2019)
Introduction and aim: Data on the efficacy and tolerance of interferon-free treatment in chronic hepatitis C (CHC) in elderly patients are limited in phase II-III trials. Material and methods: A prospective cohort of adult patients with CHC treated i
Externí odkaz:
https://doaj.org/article/7eaaff1a810d4f418777cb7edb3c707b
Autor:
Camille, Barrault, Shuaib, Alqallaf, Hortensia, Lison, Isabelle, Lamote-Chaouche, Valérie, Bourcier, Joëlle, Laugier, Thierry, Thevenot, Damien, Labarriere, Marie-Pierre, Ripault, Antonia, Le Gruyer, Charlotte, Costentin, Véronique, Behar, Hervé, Hagege, Camille, Jung, Jean-François, Cadranel
Publikováno v:
Alcohol and alcoholism (Oxford, Oxfordshire).
Alcohol-related cirrhosis is a frequent and difficult-to-treat disease. Despite the low hepatic metabolism of baclofen, data on its use in this subgroup are scarce. The French multicenter Observatory of patients treated with Baclofen for Alcohol DEpe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1a8d844cd264ebfa5a69e9832399060e
https://pubmed.ncbi.nlm.nih.gov/36527321
https://pubmed.ncbi.nlm.nih.gov/36527321
Autor:
Jean-Marie Péron, Marie-Angèle Robic, Maeva Guillaume, Fiona Chautant, Jean-François Cadranel, Christophe Bureau, Hortensia Lison, Charlène Cool, Véronique Duhalde
Publikováno v:
World Journal of Hepatology
Background Hepatic encephalopathy (HE) is a major complication of cirrhosis with independent prognostic significance. The current management of HE is mainly based on lactulose. Rifaximin has been shown to decrease the risk of HE recurrence in patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bee901ac3486683b2b0acbba13d8960
https://pubmed.ncbi.nlm.nih.gov/31984117
https://pubmed.ncbi.nlm.nih.gov/31984117
Publikováno v:
La Presse Médicale. 45:815-823
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4cece98c73083489952d0e41d670a335
https://doi.org/10.1016/j.lpm.2016.04.024
https://doi.org/10.1016/j.lpm.2016.04.024
Autor:
Armand Garioud, Hortensia Lison, Bruno Degano, Thierry Thevenot, Jean-François Cadranel, Delphine Weil
Publikováno v:
La Presse Médicale. 45:509-514
Points essentiels Le syndrome hepato-pulmonaire (SHP) est defini par l’association d’une hypertension portale, d’un gradient alveolo-arteriel en oxygene eleve et de dilatations vasculaires intra-pulmonaires. Les mecanismes physiopathologiques d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a55e84f6caaa5973beaac48c01f77d1
https://doi.org/10.1016/j.lpm.2016.02.017
https://doi.org/10.1016/j.lpm.2016.02.017
Autor:
Yves Deugnier, Zeineb Ben Ali, Isabelle Renard, Caroline Jezequel, Jean-Baptiste Nousbaum, Antonia Le Gruyer, Jean-François Cadranel, Marianne Latournerie, Michel Robaszkiewicz, Marie Feillant, Florence Tanné, Armand Garioud, Hortensia Lison, Dominique Guyader, Aurélien Delluc
Publikováno v:
European Journal of Gastroenterology and Hepatology
European Journal of Gastroenterology and Hepatology, Lippincott, Williams & Wilkins, 2016, 28 (2), pp.164-72. ⟨10.1097/MEG.0000000000000506⟩
European Journal of Gastroenterology & Hepatology
European Journal of Gastroenterology & Hepatology, 2016, 28 (2), pp.164-72. ⟨10.1097/MEG.0000000000000506⟩
European Journal of Gastroenterology and Hepatology, Lippincott, Williams & Wilkins, 2016, 28 (2), pp.164-72. ⟨10.1097/MEG.0000000000000506⟩
European Journal of Gastroenterology & Hepatology
European Journal of Gastroenterology & Hepatology, 2016, 28 (2), pp.164-72. ⟨10.1097/MEG.0000000000000506⟩
International audience; BACKGROUND AND AIMS: In many countries, current treatment for patients with chronic hepatitis C involves a combination of peginterferon and ribavirin, associated with a protease inhibitor for hepatitis C virus genotype 1. More
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91504cb9d32af38759586909b7c3e47f
https://doi.org/10.1097/meg.0000000000000506
https://doi.org/10.1097/meg.0000000000000506
Autor:
Christophe Pilette, Yann Le-Bricquir, Frédéric Heluwaert, Isabelle Rosa-Hézode, Jean-Pierre Arpurt, Jean Henrion, Bruno Lesgourgues, Bertrand Condat, Gilles Macaigne, Georges Barjonet, Christophe Renou, Hervé Hagège, Ramuntxo Arotcarena, E. Maringe, Bertrand Tissot, Stéphanie de Montigny-Lenhardt, Edmond Geagea, Alexandre Pariente, Séverine Hommel, Frangois Bourhis, Xavier Causse, Jean-Frangois Cadranel, Hatem Salloum, Marie-Pierre Ripault, Arnaud Pauwels, H. Labadie, Andre-Jean Remy, Hortensia Lison, Vincent Jouannaud, Matthieu Schnee, David Zanditenas
Publikováno v:
Annals of Hepatology, Vol 18, Iss 1, Pp 193-202 (2019)
Introduction and aim Data on the efficacy and tolerance of interferon-free treatment in chronic hepatitis C (CHC) in elderly patients are limited in phase II-III trials. Material and methods A prospective cohort of adult patients with CHC treated in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bce1be6c6da03d79fd7f2b907f3cc8de
https://pubmed.ncbi.nlm.nih.gov/31113590
https://pubmed.ncbi.nlm.nih.gov/31113590
Autor:
Gilles Macaigne, Bruno Lesgourgues, H. Labadie, Jean-Pierre Arpurt, David Zanditenas, Marie-Pierre Ripault, Bertrand Condat, Bertrand Tissot, Jean Henrion, Jean-François Cadranel, Ramuntxo Arotcarena, Frédéric Heluwaert, Xavier Causse, Arnaud Pauwels, F. Bourhis, Hervé Hagège, Matthieu Schnee, Edmond Geagea, Christophe Renou, Alexandre Pariente, Yann Le eaBricquir, Georges Barjonet, Vincent Jouannaud, Isabelle Rosa-Hézode, André-Jean Remy, Christophe Pilette, Hatem Salloum, Hortensia Lison, Séverine Hommel, E. Maringe, Stéphanie de Montigny-Lenhardt
Publikováno v:
Presse medicale (Paris, France : 1983). 48(3 Pt 1)
Summary Background and aims According to clinical trials, the treatment of patients with chronic hepatitis C (CHC) with second-generation direct acting antiviral agents (DAAs) is highly efficient and well tolerated. The goal of this study was to inve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be0088c638254aac88734f530eabb26a
https://pubmed.ncbi.nlm.nih.gov/30853287
https://pubmed.ncbi.nlm.nih.gov/30853287
Autor:
Christophe Bureau, Je Combining Acute Accent Rôme Dumortier, Anis Sfaxi, Manon Allaire, Laurent Spahr, Jacques Denis, Vincent Di Martino, Gilles Macaigne, Jean-Pierre Bronowicki, Jean-Didier Grangé, Vincent Jouannaud, Salah Zerkly, Teresa Antonini, Isabelle Ollivier-Hourmand, Alexandre Pariente, Alexandre Louvet, He Combining Acute Accent le Combining Grave Accent Ne Blasco-Perrin, Pierre Iaria, Karine Dupont, Jean-Baptiste Nousbaum, Carine Chagneau-Derrode, Agne Combining Grave Accent S Pe Combining Acute Accent Laquier, Patrice Cacoub, Thierry Thevenot, Je Combining Acute Accent Rome Gournay, Jean-François Cadranel, Thong Dao, Ryme Chentouh, Christine Silvain, Isabelle Rosa-He Combining Acute Accent Zode, Nathalie Ganne-Carrie Combining Acute Accent, Xavier Causse, Marc Bourlie Combining Grave Accent Re, Laurent Alric, Armand Garioud, Hortensia Lison
Publikováno v:
European Journal of Gastroenterology and Hepatology
European Journal of Gastroenterology and Hepatology, Lippincott, Williams & Wilkins, 2018, 10, pp.1216-1223
European Journal of Gastroenterology and Hepatology, Lippincott, Williams & Wilkins, 2018, 10, pp.1216-1223
International audience; Background: Data on infectious endocarditis (IE) in patients with liver cirrhosis (LC) are sparse. We aimed to describe the characteristics and predictors of mortality from IE in patients with LC.Patients and methods: Overall,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f220fe4be93e5fa34fe69140d7a4a9d
https://ut3-toulouseinp.hal.science/hal-03143213
https://ut3-toulouseinp.hal.science/hal-03143213
Autor:
Teresa Antonini, Alexandre Louvet, Brigitte Bernard-Chabert, Vincent Jouannaud, Arnaud Pauwels, H. Labadie, Jean-Baptiste Nousbaum, Jacques Denis, Jean-François Cadranel, N. Talbodec, Xavier Amiot, Victor de Ledinghen, Nicolas Carbonell, Laurent Alric, Vincent Leroy, Laure Elkrief, Thong Dao, Thierry Thevenot, Dominique Thabut, Bertrand Hanslik, Christophe Bureau, Gilles Macaigne, Philippe Sogni, Armand Garioud, Hortensia Lison, Armand Abergel
Publikováno v:
Journal of clinical gastroenterology. 51(9)
Introduction The use of human albumin for the management of cirrhosis has increased. Recommendations have been published for therapeutic paracentesis (TP), spontaneous bacterial peritonitis (SBP), and type 1 hepatorenal syndrome (HRS). The goal of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69bdf18d6467aae8833a41a1d83678e7
https://pubmed.ncbi.nlm.nih.gov/28787354
https://pubmed.ncbi.nlm.nih.gov/28787354